Nuvation Bio Inc (NUVB) Clearly Signals Buy-Into the Stock: Don’t ignore the signals

With 3.01 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.38 million shares. The 52-week range on NUVB shows that it touched its highest point at $4.16 and its lowest point at $1.67 during that stretch. It currently has a 1-year price target of $7.75. Beta for the stock currently stands at 1.48.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NUVB was down-trending over the past week, with a drop of -11.22%, but this was down by -21.21% over a month. Three-month performance dropped to -37.02% while six-month performance fell -43.12%. The stock lost -2.67% in the past year, while it has lost -31.58% so far this year. A look at the trailing 12-month EPS for NUVB yields -2.17 with Next year EPS estimates of -0.56. For the next quarter, that number is -0.13. This implies an EPS growth rate of -514.29% for this year and 73.84% for next year.

Float and Shares Shorts:

At present, 335.25 million NUVB shares are outstanding with a float of 226.09 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NUVB since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.04898 being high and -$2.22545 being low. For NUVB, this leads to a yearly average estimate of -$2.098. Based on analyst estimates, the high estimate for the next quarter is -$0.11 and the low estimate is -$0.13. The average estimate for the next quarter is thus -$0.12.

Summary of Insider Activity:

Insiders traded NUVB stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.